Deutsche Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-315
Closed -$4K 6242
2014
Q4
$4K Buy
+315
New +$3.94K ﹤0.01% 5938

Other funds holding HZNP

Deutsche Bank's HZNP Position: Q4 2023 in Review

Deutsche Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 728,802 shares — an estimated $84.3M sold.

Deutsche Bank first reported a position in HZNP in Q2 2013 and held it in 42 quarters. The position peaked at $235M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Deutsche Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Deutsche Bank sold 728,802 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $84.3M.
  • Deutsche Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 42 quarters.
  • Deutsche Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $235M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.